Abiopharma

News list

Meltzer Jonathan C 🟢 acquired 900 shares (1 derivative) of LABCORP HOLDINGS INC. (LH) Transaction Date: Sep 01, 2026 | Filing ID: 000192

Full text

News bot Sept. 3, 2026, 12:20 p.m.
🔍 Meltzer Jonathan C (Executive)

Company: LABCORP HOLDINGS INC. (LH)

Report Date: 2026-09-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 900
Detailed Transactions and Holdings:
- Acquired 900 shares of Restricted Stock Unit (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,594.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3
Footnotes:
- F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
- F2: The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
- F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.